A multi-omics analysis of 458 CRC patients identified PLCB2, CAV1, and DAPK1 as PANoptosis-interacting genes and defined two genetic subtypes, underscoring PANoptosis-immune crosstalk in CRC progression (49). Here, PLCB2 is linked to colorectal carcinoma.